Roman Fischer
Associate Professor and Head of Discovery Proteomics Facility
In the Discovery Proteomics Facility of the Target Discovery Institute we provide advice in experimental design, sample preparation, sample analysis with state-of-the-art LCMS workflows and data analysis to researchers from Oxford University and national and international collaborators. We routinely use label-free quantitation, SILAC, TMT, SWATH and other methodologies on diverse samples (i.e. cells, tissues, immuno precipitates et al.) and have developed sample preparation techniques to access the deep proteome form little sample amounts using instrumentation such as Orbitrap Fusion Lumos or TimsTOF Pro.
My own interests evolve around clinical proteomics and applications for the spatial characterisation of the proteome in biological structures such as tissues and tumours. In addition, I am developing methodologies for the proteome characterisation of clinical cohort samples at high-throughput.
Recent publications
-
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors.
Journal article
Singh S. et al, (2025), Nature
-
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord
Journal article
Feneberg E. et al, (2025), Acta Neuropathologica Communications, 13
-
Acidosis attenuates the hypoxic stabilization of HIF-1α by activating lysosomal degradation
Journal article
White B. et al, (2025), Journal of Cell Biology, 224
-
A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.
Journal article
Wang C-Y. et al, (2025), Commun Med (Lond), 5
-
A new paradigm of islet adaptations in human pregnancy: insights from immunohistochemistry and proteomics
Journal article
Seedat F. et al, (2025), Nature Communications, 16